PGHL — Procter & Gamble Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapHigh Flyer

Annual income statement for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	9 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,087	11,144	12,296	11,513	9,342
Cost of Revenue
Gross Profit	6,608	6,888	7,824	7,425	6,167
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,923	8,733	9,330	8,929	6,325
Operating Profit	2,164	2,411	2,966	2,584	3,017
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,333	2,534	3,142	2,733	3,116
Provision for Income Taxes
Net Income After Taxes	1,768	1,925	2,295	2,010	2,344
Net Income Before Extraordinary Items
Net Income	1,768	1,925	2,295	2,010	2,344
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,768	1,925	2,295	2,010	2,344
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	107	119	143	131	142
Dividends per Share
Special Dividends per Share